Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 2/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | RECQL | P46063 | 1/20 | 0.34 |
| ▸ | USP30 | Q70CQ3 | 1/20 | 0.34 |
| ▸ | SLC5A2 | P31639 | 1/20 | 0.34 |
| ▸ | PKM | P14618 | 1/20 | 0.33 |
| ▸ | MAOA | P21397 | 1/20 | 0.33 |
| ▸ | MAOB | P27338 | 1/20 | 0.33 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.33 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.33 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13651823 | 0.94 | MAPT (0.39) | MAPTALDH1A1NPC1LMNAPKM | |
| SCHEMBL14193812 | 0.93 | LMNA (0.39) | MAPTALDH1A1NPC1LMNAKDM4E | |
| SCHEMBL14193810 | 0.93 | NPC1 (0.37) | MAPTALDH1A1NPC1LMNAPKM | |
| SCHEMBL13651821 | 0.89 | ALDH1A1 (0.36) | MAPTALDH1A1NPC1LMNAKDM4E | |
| SCHEMBL13651779 | 0.86 | ALDH1A1 (0.49) | MAPTALDH1A1NPC1LMNAMAOA | |
| SCHEMBL4806456 | 0.86 | NPC1 (0.48) | MAPTALDH1A1NPC1LMNAMAOA | |
| SCHEMBL10329383 | 0.86 | ALDH1A1 (0.33) | MAPTALDH1A1NPC1LMNAKDM4E | |
| SCHEMBL4807583 | 0.85 | EPHX2 (0.39) | MAPTALDH1A1NPC1LMNAKDM4E | |
| SCHEMBL14193813 | 0.84 | EPHX2 (0.40) | MAPTALDH1A1NPC1LMNAKDM4E | |
| SCHEMBL14193797 | 0.84 | LMNA (0.51) | MAPTALDH1A1NPC1LMNAMAOA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090252895-A1 | Actinic ray curable composition, actinic ray curable ink and image formation method employing the ink | KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) | 2009-10-08 | — | — | US | disclosed |
| US-20090252895-A1 | Actinic ray curable composition, actinic ray curable ink and image formation method employing the ink | KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) | 2009-10-08 | — | — | US | disclosed |
| US-20080107821-A1 | Polymerizable Actinic Radiation Curable Composition, Polymerization Method, Actinic Radiation Curable Ink and Image Formation Method, and Ink Jet Recording Apparatus and Epoxy Compound | KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) | 2008-05-08 | — | — | US | disclosed |
| US-20080107821-A1 | Polymerizable Actinic Radiation Curable Composition, Polymerization Method, Actinic Radiation Curable Ink and Image Formation Method, and Ink Jet Recording Apparatus and Epoxy Compound | KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) | 2008-05-08 | — | — | US | disclosed |
| US-7360883-B2 | Active ray curable ink, image forming method and ink-jet recording apparatus | KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) | 2008-04-22 | — | — | US | disclosed |
| US-7360883-B2 | Active ray curable ink, image forming method and ink-jet recording apparatus | KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) | 2008-04-22 | — | — | US | disclosed |
| US-20070219292-A1 | INK SET FOR INK-JET RECORDING, POLYMERIZATION METHOD AND IMAGE FORMING METHOD | KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) | 2007-09-20 | — | — | US | disclosed |
| US-20070219292-A1 | INK SET FOR INK-JET RECORDING, POLYMERIZATION METHOD AND IMAGE FORMING METHOD | KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) | 2007-09-20 | — | — | US | disclosed |
| EP-1829936-A1 | ACTIVE RAY-CURABLE COMPOSITION, ACTIVE RAY-CURABLE INK AND IMAGE-FORMING METHOD | Konica Minolta Medical & Graphic, Inc. (JP) | 2007-09-05 | — | — | EP | disclosed |
| US-20050190252-A1 | Active ray curable ink, image forming method and ink-jet recording apparatus | KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) | 2005-09-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080107821-A1 | Polymerizable Actinic Radiation Curable Composition, Polymerization Method, Actinic Radiation Curable Ink and Image Formation Method, and Ink Jet Recording Apparatus and Epoxy Compound | CBR3, CBR1, CNR1 | MAPT 3075/4885ALDH1A1 3110/4885NPC1 4389/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.